The National Nuclear Security Administration is set to start negotiations with NorthStar Medical Radioisotopes, SHINE Medical Technologies, Niowave and Northwest Medical Isotopes, potentially providing each company as much as $15 million to facilitate domestic production of molybdenum-99 without using highly enriched uranium. "This industry outreach helps to develop a reliable domestic supply of a vital medical isotope, reduce dependence on foreign imports, and bring new opportunity to the heartland," Energy Secretary Rick Perry said.
Feds to begin negotiations with companies on domestic Mo-99 production
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.